Enzymes for starch processing

Details for Australian Patent Application No. 2011203101 (hide)

Owner Novozymes A/S Novozymes North America, Inc.

Inventors Fukuyama, Shiro; Matsui, Tomoko; Soong, Chee-Leong; Allain, Eric; ViksoNielsen, Anders; Udagawa, Hiroaki; Liu, Ye; Duan, Junxin; Wu, Wenping; Andersen, Lene Nonboe; Landvik, Sara

Agent Shelston IP

Pub. Number AU-A-2011203101

Parent 2005319074

Filing date 24 June 2011

Wipo publication date 14 July 2011

International Classifications

C12P 7/06 (2006.01) Preparation of oxygen-containing organic compounds

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 9/32 (2006.01) Enzymes, e.g. ligases (6.)

C12N 15/74 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Event Publications

14 July 2011 Application Open to Public Inspection

  Published as AU-A-2011203101

14 July 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011203102-Sample container with physical fill-line indicator

2011203100-Magnetically controllable drug and gene delivery stents